Venus Concept Inc. (VERO) |
| 0.311 0.008 (2.64%) 04-06 16:00 |
| Open: | 0.2683 |
| High: | 0.311 |
| Low: | 0.2683 |
| Volume: | 43 |
| Market Cap: | 1(M) |
| PE Ratio: | -0.01 |
| Exchange: | NASDAQ Global Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.51 |
| Resistance 1: | 0.41 |
| Pivot price: | 0.32 |
| Support 1: | 0.25 |
| Support 2: | 0.21 |
| 52w High: | 12.93 |
| 52w Low: | 0.247 |
Venus Concept Inc. is a medical technology firm that specializes in offering a range of innovative minimally and non-invasive solutions for medical aesthetics and hair restoration. Operating both domestically in the U.S. and internationally, the company is responsible for the development, market introduction, and ongoing provision of these advanced technologies and associated services. Its comprehensive product lineup features several cutting-edge devices: Venus Legacy: A non-invasive system primarily used in dermatological and general surgical procedures for female patients. Venus Versa: A versatile, multi-application platform designed for various aesthetic and cosmetic treatments. Venus Viva: A portable and advanced fractional radiofrequency (RF) system utilized in dermatological procedures for skin ablation and resurfacing. Venus Fiore: Employs non-thermal RF technology, combined with massage and magnetic field pulses, to address a variety of medical conditions. Venus Bliss: Targets non-invasive lipolysis of the abdomen and flanks, suitable for individuals with a body mass index (BMI) of 30 or below. Venus Glow: A specialized dermabrasion device aimed at enhancing overall skin appearance. NeoGraft: Provides advanced hair restoration using an automated Follicular Unit Extraction (FUE) and implantation system. Venus Velocity & Venus Epileve: These devices facilitate permanent hair removal, reduction, and the treatment of pseudofolliculitis barbae. ARTAS iX: A robotic system that assists physicians during hair transplantation by automating the identification, extraction, and implantation of follicular units from the scalp, as well as the creation of recipient sites. The company's corporate headquarters are located in Toronto, Canada.
| EPS | -45.260 |
| Book Value | 1.440 |
| PEG Ratio | 0.00 |
| Gross Profit | 20.371 |
| Profit Margin (%) | -92.76 |
| Operating Margin (%) | -68.93 |
| Return on Assets (ttm) | -32.4 |
| Return on Equity (ttm) | -794.5 |
Wed, 13 May 2026
Venus Concept Announces Senior Management Changes - Barchart.com
Wed, 01 Apr 2026
Venus Concept Announces Completion of Common Stock Sale and Short-Form Merger - Yahoo Finance
Thu, 05 Mar 2026
Nasdaq, S&P 500 Futures Slide As Trump Ramps Up Greenland Threats: Why NFLX, CRML, TSLA, VERO, SRXH Are On Traders' Radar Today - Stocktwits
Wed, 21 Jan 2026
This Microcap Company Announced Plans To Delist Just Days After The Stock Surged 450% — What Happened? - Stocktwits
Mon, 10 Nov 2025
Venus Concept Inc. Receives FDA Clearance for Next-Generation Venus NOVA Aesthetic Treatment Platform - Quiver Quantitative
Thu, 14 Aug 2025
Venus Concept Inc. Reports Q2 2025 Financial Results, Highlights Revenue Growth and Strategic Initiatives - Quiver Quantitative
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |